Bayer retains rights to sorafenib in Russia
German pharmaceutical manufacturer Bayer refused compensation of more than 400 million rubles. from Nativa (renamed Spectrum) for the use of...
German pharmaceutical manufacturer Bayer refused compensation of more than 400 million rubles. from Nativa (renamed Spectrum) for the use of...